Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction

Qiang Ma

doi:10.1124/pharmrev.122.000629

Article Information

PHARMREV-AR-2022-000629

DOI

https://doi.org/10.1124/pharmrev.122.000629

PubMed

36669831

Published By

American Society for Pharmacology and Experimental Therapeutics

Print ISSN

0031-6997

Online ISSN

1521-0081

History

Published online January 20, 2023.

© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution CC BY License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Author Information

Qiang Ma1,*

¹Toxicology & Molecular Pharmacology Branch, TMBB/HELD/NIOSH/CDC, United States

↵* Corresponding Author:
Qiang Ma, Toxicology & Molecular Pharmacology Branch, TMBB/HELD/NIOSH/CDC, 1000 Frederick Lane, Morgantown, West Virginia, 26505-2888, United States. E-mail: qam1{at}cdc.gov